Related Experiment Video
Updated: Jun 13, 2026

Measurement of Cyclic Guanosine Monophosphate (cGMP) in Solid Tissues using Competitive Enzyme-Linked Immunosorbent Assay (ELISA)
Published on: July 3, 2025
Should we measure C-reactive protein on earth or just on JUPITER?
Ambareesh Bajpai1, Abhinav Goyal, Laurence Sperling
1Department of Cardiology, Emory University, Atlanta, Georgia, USA.
Insights
High-sensitivity C-reactive protein (hs-CRP) shows inflammation
Area of Science:
- Cardiovascular Medicine
- Inflammation Biology
- Biomarker Research
Background:
- Inflammation plays a key role in atherosclerosis development.
- High-sensitivity C-reactive protein (hs-CRP) is investigated as a cardiovascular risk marker.
- Existing data on hs-CRP and cardiovascular risk requires further clinical interpretation.
Purpose of the Study:
- To comprehensively review data linking hs-CRP to cardiovascular risk.
- To analyze the impact of the JUPITER trial on hs-CRP's clinical utility.
- To provide an evidence-based assessment of hs-CRP in cardiovascular risk stratification.
Main Methods:
- Literature review of studies on hs-CRP and cardiovascular risk.
- Focused analysis of the JUPITER trial findings.
- Synthesis of evidence for clinical application.
Main Results:
- Data consistently links hs-CRP to cardiovascular risk, but clinical relevance remains debated.
- The JUPITER trial has intensified discussions on hs-CRP's utility in primary prevention.
- Current evidence supports hs-CRP as a marker but its independent role in guiding therapy needs careful consideration.
Conclusions:
- hs-CRP is a valuable marker reflecting inflammatory processes in atherosclerosis.
- The clinical utility of hs-CRP in cardiovascular risk assessment, particularly in primary prevention, requires nuanced interpretation.
- Further research and guideline refinement are necessary to optimize the use of hs-CRP in patient management.
Abstract:
Evidence for the role of inflammation in the pathogenesis of atherosclerosis is compelling and has generated interest in high-sensitivity C-reactive protein (hs-CRP) as a marker of cardiovascular risk. Data regarding hs-CRP and cardiovascular risk, though largely consistent, is of unclear clinical relevance. Most recently, the Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) trial has led to further debate regarding the utility of hs-CRP. This article provides a comprehensive review of the data regarding cardiovascular risk and hs-CRP with an emphasis on the JUPITER trial and concludes with an evidence-based analysis of the current role of hs-CRP in cardiovascular risk assessment.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acceleration due to Gravity on Other Planets
Astronomical observations are thus used to measure the acceleration due to gravity on other planets. This can be determined by observing the effect of a planet's gravity on objects close to it. The crucial factor that helps in this...
Drug Concentrations: Measurements
Plasma —...
Measuring Reaction Rates
Measurement of Blood Pressure
Measuring Acceleration Due to Gravity
A simple pendulum can be described as a point mass and a string. Meanwhile, a physical pendulum is any object whose oscillations are similar to a simple pendulum, but cannot be modeled as a point mass on a string because its mass is distributed over a larger area. The behavior of a physical pendulum can be modeled using the principles of...

